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esponsibility of InsAbstract A new dibenzylbutyrolactone lignan named matairesinol 40-O-b-D-cellobioside (1),
together with a known compound (7R, 8S)-dihydrodehydrodiconiferyl alcohol (2) was isolated
from Caulis Trachelospermi. The extract of Caulis Trachelospermi, which was separated by 80%
alcohol extraction and subsequent HP-20 macroporous resin column chromatography, and its main
components trachelogenin (3), nortrachelogenin (4), matairesinol (5) showed moderate inhibiting
activities on NF-kB signaling pathway induced by TNFa, with the IC50 values of 17.7 mg/mL,
17.9 mM, 49.4 mM and 29.1 mM, respectively.
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Chencheng Zhu et al.1101. Introduction
Traditional Chinese medicine Caulis Trachelospermi is the
stems and leaves of Trachelospermum jasminoides (Lindl.)
Lem., which is mainly distributed in Henan, Anhui, Hubei,
Shandong and Guangxi provinces in China. It is prescribed for
rheumatic arthralgia, aching of the loins and knees, traumatic
injuries1 and its medicinal values such as anti-cancer, anti-
inﬂammation had been reported2,3. Chemical investigation
indicated that it mainly contained lignans, ﬂavonoids and
triterpenoids4–6. In our previous study, the extract of Caulis
Trachelospermi, which was separated by 80% alcohol extrac-
tion and subsequent HP-20 macroporous resin column chro-
matography, showed marked anti-inﬂammatory activity in
animal model and 28 compounds including 18 dibenzylbutyr-
olactone lignans had been isolated from it7–10. Nuclear factor-
kB (NF-kB) and its signaling pathway play an essential role in
the development of innate and adaptive immunity and as
therapeutic target for inﬂammatory diseases and cancer11–13.
Our recent study revealed the extract of Caulis Trachelospermi
had moderate inhibitory activity on the pathway induced by
TNFa. Subsequent searching for active components led to the
discovery of three active components trachelogenin (3), nor-
trachelogenin (4), matairesinol (5) and two new isolated
compounds including a new compound matairesinol 40-O-b-
D-cellobioside (1) and a known compound (7R, 8S)-dihydro-
dehydrodiconiferyl alcohol (2) which was isolated from T.
jasminoides for the ﬁrst time (Fig. 1). In this paper, we report
the isolation and structure elucidation of compound 1 as well
as the NF-kB pathway inhibiting activities of the extract and
compounds 3–5.2. Results and discussion
Compound 1 was obtained as a white amorphous powder. Its
molecular formula was deduced as C32H42O16 on the basis of
[MþNa]þ ion at m/z 705.2346 (Calcd. 705.2371) in the HR-
TOF-MS. The 1H NMR spectrum (see Table 1) displayed signals
for two methine protons at d 2.74 (dd, J¼9.0, 6.5 Hz, H-80) and
2.43 (m, H-8), an oxygenated methylene at d 4.09 (dd, J¼8.5,Figure 1 Structures o7.8 Hz, Ha-9) and 3.87 (t, J¼8.5 Hz, Hb-9), two sets of ABX
systems of the phenyl protons at d 6.62 (d, J¼2.0 Hz, H-2), 6.66
(d, J¼8.0 Hz, H-5), 6.49 (dd, J¼2.0, 8.0 Hz, H-6) and d 6.79 (d,
J¼1.7 Hz, H-20), 6.99 (d, J¼8.4 Hz, H-50), 6.68 (dd, J¼1.7,
8.4 Hz, H-60), two benzylic protons at d 2.44–2.52 (m, H-7) as
well as the other two benzylic protons at d 2.80 (m, H-70). The
13C NMR spectrum, in combination with the HMQC spectrum,
showed signals for a carboxyl carbon, twelve aromatic carbons
including six quaternary carbons and six tertiary carbons, an
oxygenated methylene carbon, four high-ﬁeld carbons including
two methylene carbons and two methine carbons. This indicated
the characteristic signals of dibenzylbutyrolactone lignan.
Furthermore, the 1H NMR spectrum showed two methoxy
groups at d 3.72 and 3.70, which correlated with the quaternary
carbon at d 148.6 (C-30) and 147.5 (C-3), respectively. Accord-
ingly, the aglycone of 1 was considered to be matairesinol (5)
which has been isolated from Caulis Trachelospermi. These
assignments were further deﬁned by HMBC spectrum (see
Table 1). In addition, the spectra showed signals for two sugar
anomeric protons at d 4.94 (d, J¼7.9 Hz) and 4.28 (d, J¼8.0 Hz),
a phenolic hydroxy group at d 8.82 (s, 4-OH) and twelve sugar
carbons, suggesting a disaccharide group which was combined
with two hexose in the structure. In comparison with its isomer
matairesinol 40-O-b-gentiobioside which was isolated from Caulis
Trachelospermi previously9, all signals of 1 were identical except
the sugar moiety. Compound 1 had relative low chemical shift of
C-600 (Dd¼8.2) and high chemical shift of C-400 (Dd¼10.4) C-400 of
1 had HMBC correlation with H-100 0 (d 4.28) of another glucosyl
residue. Therefore, the component sugar was considered to be b-
D-glucopyranosyl-(1-4)-b–D- glucopyranoside (b-D-cellobiosyl),
which was conﬁrmed due to the sugar moiety of 1 having the
identical carbon signals with that of 5-methyl-coumarin-4-cellobio-
side14,15. HMBC correlation between the cellobiosyl anomeric
proton (H-100) at d 4.94 and the carbon at d 145.0 or 145.1
revealed the cellobiosyl group attached at C-4 or C-40. NOE
correlation between H-100 and H-50 (d 6.99) indicated the O-b-D-
cellobiosyl group attached at C-40. Its identical carbon chemical
shifts with those of the known lignan matairesinol 40-O-b-
gentiobioside9 indicated its stereochemistry was 8R, 80R or 8S,
80S. Compound 1 had negative cotton effects at 231.5 and
278.0 nm ([y]231.5 14368, [y]278.0 2582) in the CD spectrum,f compounds 1–5.
Table 1 1H, 13C NMR and HMBC data of 1 in DMSO-d6
a
(d in ppm, J in Hz).
Position dC dH HMBC (H-C)
1 129.6
2 112.7 6.62 (1H, d, 2.0) C-4, 6, 7
3 147.5
4 145.0
5 115.4 6.66 (1H, d, 8.0) C-1, 3
6 120.8 6.49 (1H, dd, 2.0, 8.0) C-2, 4
7 36.9 2.44-2.52 (2H, m) C-1, 2, 8, 9
8 40.9 2.43 (1H, m)
9 70.8 4.09 (1H, dd, 8.5, 7.8)
3.87 (1H, t, 8.5)
3-OCH3 55.5 3.70 (3H, s) C-3
4-OH 8.82 (1H, s)
10 131.9
20 113.8 6.79 (1H, d, 1.7) C-30, 40, 60, 70
30 148.6
40 145.1
50 115.0 6.99 (1H, d, 8.4) C-10, 30, 40
60 121.3 6.68 (1H, dd, 1.7, 8.4) C-20, 40
70 33.5 2.80 (2H, m) C-10, 60, 80, 90
80 45.6 2.74 (1H, dd, 9.0, 6.5)
90 178.6
30–OCH3 55.5 3.72 (3H, s) C-30
100 99.6 4.94 (1H, d, 7.9) C-40
200 73.0
300 75.2
400 79.9
500 74.9
600 60.0
100 0 103.2 4.28 (1H, d, 8.0) C-40 0
200 0 73.3
300 0 76.8
400 0 70.1
500 0 76.5
600 0 61.1
a400 and 100 MHz for 1H and 13C NMR, respectively.
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that 8R, 80R-isomer has negative cotton effects at 233 and 276 nm
in contrast to the positive cotton effects of 8S, 80S-isomer15.
Consequently, its structure was determined as matairesinol 40-O-b-
D-glucopyranosyl-(1-4)-b-D-glucopyranoside, which was also
named matairesinol 40-O-b-D-cellobioside. To our knowledge,
it might be the ﬁrst cellobioside of dibenzylbutyrolactone lignan.
The known compound 2 was identiﬁed as (7R, 8S)-dihydrodehy-
drodiconiferyl alcohol on the basis of comparison of its 1H and
13C NMR spectroscopic data with the reported16.
In the in vitro bioassays for the activity on NF-kB signaling
pathway induced by TNFa, the extract of Caulis Trachelospermi,
which was separated by 80% alcohol extraction and subsequent
HP-20 macroporous resin column chromatography showed mod-
erate inhibiting activity (IC50 17.7 mg/mL) in comparison with the
positive control Bay 11-7082 (IC50 5.8 mM). Subsequent examina-
tion for the active components revealed that only three dibenzyl-
butyrolactone lignans trachelogenin (3), nortrachelogenin (4),
matairesinol (5) had accordant activities (IC50 17.9, 49.4,
29.1 mM) in contrast to their glycosides compound 1, tracheloside,
nortracheloside, matairesinoside, nortrachelogenin 8-O-glucoside,nortrachelogenin 5-C-glucoside and ﬂavonoid compound apigenin
7-O-neohesperidoside.3. Experimental
3.1. General procedures
Optical rotations were performed on polAAr3005 polarimeter.
CD spectra were acquired on a Biologic M450 spectropolarimeter.
NMR spectra were recorded on a JNM-ECA-400 NMR spectro-
meter with TMS as internal standard. The HR-TOF-MS spectra
were recorded on an Agilent 6520 Q-TOF mass spectrometer.
ESI-MS was measured with an API-3000 spectrometer. Column
chromatography (CC) was carried out on HP-20 macroporous
resin (Mitsubishi Chemical Industries Ltd., Japan), polyamide
(60–90 mesh), silica gel (200–300 mesh), ODS (50 mm, YMC,
Japan) and monitored by TLC. Semi-preparative HPLC was
carried out on an Agilent 1100 HPLC equipped with DAD
detector and an YMC C18 column (5 mm, 250 mm 10 mm).
3.2. Plant and compound materials
Caulis Trachelospermi (the stems and leaves of T. jasminoides
(Lindl.) Lem) were purchased from Beijing Qijing Chinese
Herbs Factory, Beijing, in 2008. The sample was authenticated
by senior engineer Qiyun Ma, Institute of Pharmacology and
Toxicology, Academy of Military Medical Sciences, Beijing,
China. A voucher specimen (No. 20080130) has been depos-
ited at the Department of Natural Products Chemistry,
Institute of Pharmacology and Toxicology, Academy of
Military Medical Sciences, Beijing, China. Compounds tra-
chelogenin, nortrachelogenin, matairesinol, tracheloside, nor-
tracheloside, matairesinoside, nortrachelogenin 8-O-glucoside,
nortrachelogenin 5-C-glucoside and apigenin 7-O-neohesper-
idosidein for the active tests were isolated and identiﬁed in our
previous research7,10.
3.3. Extraction and isolation
Caulis Trachelospermi (160 kg) was extracted with 80% (v/v)
alcohol in the boiling temperature two times. The extract
was concentrated and diluted in 1600 L 5% alcohol and then
was centrifuged to remove the insoluble material. The solution
was past through a HP-20 macroporous resin column (100 L)
and eluted by 500 L water and 500 L 70% alcohol succes-
sively. The 70% alcohol elution was evaporated and dried to
obtain 5.3 kg product.
The product (500 g) was applied on a HP-20 macroporous resin
CC eluted with 20%, 40%, 50%, 60% and 80% alcohol
successively. The moiety of 40% and 50% alcohol elution was
each concentrated to yield fractions A and B. Fraction A was
chromatographed over polyamide eluted in turn with 10%, 80%
alcohol; the moiety of 10% alcohol elution was concentrated to
yield fraction 1. Fraction 1 was chromatographed over silica gel
gradient eluted with EtOAc–MeOH (10:1 to 1:10) and ﬁve
fractions were obtained. Fraction 1–2 (5:1) was applied on ODS
CC eluted with 25% CH3OH to give fraction 1-2-1, then puriﬁed
by semi-preparative RP-HPLC with CH3OH–H2O (40:60) to
afford compound 1 (7.0 mg). Fraction B was subjected to CC
on polyamide eluted with 20%, 30%, 40% alcohol successively,
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Fraction 1 was chromatographed over silica gel gradient eluted
with Pet-EtOAc (15:1 to 1:5) and 8 fractions were obtained.
Fraction 1-f (1:5) was applied on ODS CC eluted with 45%
MeOH to give fraction 1-f-1, then puriﬁed by semi-preparative
RP-HPLC with CH3OH–H2O (40:60) to afford compound 2
(24.8 mg).3.4. Identiﬁcation
Matairesinol 40-O-b-D-cellobioside (1): white amorphous pow-
der; [a]25D ¼38.1 (c¼0.07, CH3OH); CD (CH3OH):
[y]231.5¼14368, [y]278.0¼2582; (þ)–HR-TOF-MS: m/z
705.2346 [MþNa]þ (Calcd. for C32H42O16Na, 705.2371);
(þ)–ESI-MS: m/z 705 [MþNa]þ; ()ESI-MS: m/z 681
[MH]; 1H,13C NMR and HMBC data see Table 1.
(7R, 8S)-Dihydrodehydrodiconiferyl alcohol (2): oil;
[a]25D ¼1.1 (c¼0.31, CH3OH); 1H NMR (400 MHz,
DMSO-d6): dH 9.0 (1H, brs, 4-OH), 6.90 (1H, s, H-2), 6.75
(2H, s, H-5, 6), 6.69 (1H, s, H-60), 6.68 (1H, s, H-20), 5.40 (1H,
d, J¼6.7 Hz, H-7), 3.69 (1H, m, H-9a), 3.60 (1H, m, H-9b),
3.41 (1H, overlapped, H-8), 3.41 (2H, m, H-90), 2.51 (2H, t,
J¼7.6 Hz, H-70), 1.69 (2H, tt, J¼7.6, 6.4 Hz, H-80), 3.76 (3H,
s, 30–OCH3), 3.74 (3H, s, 3-OCH3);
1H NMR (400 MHz,
CD3OD): dH 6.93 (1H, d, J¼2.0 Hz, H-2), 6.80 (1H, dd,
J¼2.0, 8.1 Hz, H-6), 6.74 (1H, d, J¼8.1 Hz, H-5), 5.47 (1H, d,
J¼6.2 Hz, H-7), 3.81 (1H, dd, J¼5.3, 11.1 Hz,
H-9a), 3.73 (1H, dd, J¼7.3, 11.1 Hz, H-9b), 3.45 (1H, ddd,
J¼7.3, 6.2, 5.3 Hz, H-8), 6.71 (2H, s, H-20, 60), 3.55 (2H,
t, J¼6.4 Hz, H-90), 2.61 (2H, t, J¼7.3 Hz, H-70), 1.80 (2H, tt,
J¼7.3, 6.4 Hz, H-80), 3.83 (3H, s, 30–OCH3), 3.80 (3H, s, 3-
OCH3);
13C NMR (100 MHz, DMSO-d6): dC 132.5 (C-1),
110.2 (C-2), 147.5 (C-3), 145.5 (C-4), 115.3 (C-5), 118.5 (C-6),
86.9 (C-7), 53.3 (C-8), 63.0 (C-9), 135.1 (C-10), 112.3 (C-20),
143.4 (C-30), 146.3 (C-40), 129.1 (C-50), 116.5 (C-60), 31.6 (C-
70), 34.8 (C-80), 60.2 (C-90), 55.6 (3, 30–OCH3); (þ)HR-TOF-
MS: m/z 383.1480 [MþNa]þ (Calcd. for C20H24O6Na,
383.1471); (þ)–ESI-MS: m/z 383 [MþNa]þ, 378 [MþNH4]þ,
()–ESI-MS: m/z 359 [MH].3.5. Inhibiting activity on NF-kB signaling pathway
The inhibiting activity on NF-kB signaling pathway was tested
by Luciferase Assay as previous described17. HepG2/NF-kB
cells (1.5 105 per well), which were HepG2 cells stably
transfected with a NF-kB responsive ﬁreﬂy luciferase reporter
plasmid, were seeded into 96-well cell culture microplates and
allowed to grow for 24 h, then treated with test samples
followed by stimulation with TNFa. Luciferase activity was
determined using the Promega luciferase kits according to the
manufacturer’s instruction. Expression of NF-kB (% of
control) was calculated as [(Fluorescence intensity with sample
and TNFa treatmentFluorescence intensity without TNFa
treatment)/(Fluorescence intensity with TNFa treatment
Fluorescence intensity without TNFa treatment)] 100.Acknowledgments
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